默沙东2025:K药316亿美元创新高,多元管线撑起下一个周期

医药魔方Info
Feb 03

2月3日,默沙东发布2025年财报,全年总收入达650.11亿美元,同比增长1%。制药业务全年收入581.42亿美元(+1%),研发总投入为157.89亿美元(-12%)。中国市场收入为18.16亿美元(-66%),这主要受到了GARDASIL(HPV疫苗)市场需求下降的影响。Keytruda(帕博利珠单抗)作为默沙东的王牌产品,在2025年继续展现出强大的市场统治力,全年销售额达到316.80...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10